Catherine Cordonnier

Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia

I. Durand-zaleski, H. Esperou, C. Cordonnier, 2005, Bone Marrow Transplantation.

Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

J. Bourhis, H. Dombret, B. Quesnel, 2007, Leukemia.

Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

M. Labopin, O. Ringdén, K. Le Blanc, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission.

X. Troussard, V. Leblond, M. Leporrier, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cost of allogeneic bone marrow transplantation in four diseases.

D. Jolly, C. Griscelli, C. Viens-Bitker, 1989, Health policy.